Interleukin-1 receptor antagonist plasma concentration is specifically increased by alpha-2A-interferon treatment.

S Naveau; D Emilie; E Borotto; A Portier; Y Lazizi; V Giraud; L Grangeot-Keros; F Capron; P Galanaud; J C Chaput

doi:10.1016/s0168-8278(97)80171-7

Interleukin-1 receptor antagonist plasma concentration is specifically increased by alpha-2A-interferon treatment.

Identifier:nobleid.org/w1/20260515/C5038AF7

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C5038AF7.svg?ark=w1%2F20260515%2FC5038AF7)](https://nobleid.org/work/w1/20260515/C5038AF7)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Interleukin-1 receptor antagonist plasma concentration is specifically increased by alpha-2A-interferon treatment.

Identifier:nobleid.org/w1/20260515/C5038AF7

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C5038AF7.svg?ark=w1%2F20260515%2FC5038AF7)](https://nobleid.org/work/w1/20260515/C5038AF7)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work